deltatrials
Completed OBSERVATIONAL NCT00394680

Stents, Drug Eluting Stents, and CABG- Financial and Clinical Impact.

Sponsor: Hebrew University of Jerusalem

Updated 1 time since 2024 Last updated: May 26, 2011 Started: Nov 30, 2006 Completion: May 31, 2007
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Angina Unstable and Coronary Arteriosclerosis and is currently completed. Hebrew University of Jerusalem leads this study, which shows 1 recorded version since 2006 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

~Sep 2024 – present · 20 months · monthly snapshotCompleted

Change History

1 version recorded
Completed [monthly]

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Hebrew University of Jerusalem
  • Shaare Zedek Medical Center
Data source: Shaare Zedek Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.